Page last updated: 2024-08-25

zoledronic acid and Carcinoma, Epidermoid

zoledronic acid has been researched along with Carcinoma, Epidermoid in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (16.67)29.6817
2010's14 (77.78)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Billhymer, A; Lundberg, AP; Selting, KA; Tran Hoang, C1
Colak, U; Hatun, S; Kayserili, H; Mutlu, GY; Sozmen, BO; Yucel, EB1
López Jornet, P; Pons-Fuster López, E; Wang, QT; Wei, W1
Arai, N; Kurohara, K; Kutsuna, T; Murata, T; Shimizu, K; Tomeoku, A1
Domae, E; Goda, S; Hirai, Y; Ikeo, T; Tsuji, K1
Kumar, G; Kumar, N; Sundriyal, D; Walia, M1
Draenert, FG; Heymann, PG; Kämmerer, PW; Kretschmer, F; Mandic, R; Neff, A; Saydali, A1
Alvaro, PF; Lopez Jornet, P; Rosario, TM; Susana, SC1
Bezaury, AP; Nevarez-Barragan, MJ; Perez-Diaz, I; Rosas-Jurado, MG; Trejo-Rosales, R1
Arai, N; Hattori, Y; Inoue, S; Noguchi, M; Takashina, M; Tomihara, K1
Bertolini, F; Codeluppi, M; Conte, PF; De Matteis, E; Frassoldati, A; Malavasi, N; Rossi, G; Venturelli, C1
Lanigan, LG; Martin, CK; Rosol, TJ; Thudi, NK; Toribio, RE; Werbeck, JL; Wolfe, TD1
Fujii, N; Ito, H; Nakabayashi, M; Ryoke, K; Shomori, K; Tamura, T1
Balakumaran, A; Ciuleanu, TE; García-Sáenz, JA; Henry, DH; Hirsh, V; Jacobs, I; Kanarev, V; Krzakowski, M; Lipton, L; Manegold, C; Mehta, ND; Pereira, JR; Prabhash, K; Rodriguez, G; Scagliotti, GV; Siena, S; Solal-Celigny, P; Wang, H; Woll, PJ1
Cao, JY; Chen, YQ; Cui, SX; Gao, HJ; Gao, J; Guo, CH; Liu, T; Mi, YJ; Qiu, GQ; Xie, JD; Yao, SP; Zhang, YY1
Dohdoh, M; Endo, Y; Kuroishi, T; Nagai, Y; Ohki, A; Oizumi, T; Sugawara, S; Tanaka, Y1
Langer, CJ1
McKenna, KE; Morris, TC; Ramadan, KM1

Trials

1 trial(s) available for zoledronic acid and Carcinoma, Epidermoid

ArticleYear
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:12

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Denosumab; Diphosphonates; Double-Blind Method; Female; Follow-Up Studies; Humans; Imidazoles; International Agencies; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; RANK Ligand; Small Cell Lung Carcinoma; Survival Rate; Young Adult; Zoledronic Acid

2012

Other Studies

17 other study(ies) available for zoledronic acid and Carcinoma, Epidermoid

ArticleYear
Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
    Veterinary and comparative oncology, 2022, Volume: 20, Issue:4

    Topics: Animals; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Diphosphonates; Head and Neck Neoplasms; Mouth Neoplasms; Osteolysis; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid

2022
Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum.
    Journal of pediatric endocrinology & metabolism : JPEM, 2019, Dec-18, Volume: 32, Issue:12

    Topics: Bone Density Conservation Agents; Calcitriol; Carcinoma, Squamous Cell; Child, Preschool; Humans; Hypercalcemia; Male; Paraneoplastic Syndromes; Prognosis; Xeroderma Pigmentosum; Zoledronic Acid

2019
Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line.
    Archives of oral biology, 2017, Volume: 82

    Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Diosgenin; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Imidazoles; Mouth Neoplasms; Zoledronic Acid

2017
Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.
    Anticancer research, 2018, Volume: 38, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Durapatite; Humans; MCF-7 Cells; Mouth Neoplasms; Nanoparticles; Zoledronic Acid

2018
Human Vγ9Vδ2 T cells show potent antitumor activity against zoledronate-sensitized OSCC cell lines.
    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2018, Volume: 23, Issue:7

    Topics: Apoptosis; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Humans; Leukocytes, Mononuclear; Mouth Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; Tumor Cells, Cultured; Zoledronic Acid

2018
Livedo reticularis heralding hypercalcaemia of malignancy.
    BMJ case reports, 2014, May-15, Volume: 2014

    Topics: Calcitonin; Carcinoma, Squamous Cell; Diphosphonates; Diuretics; Fluid Therapy; Follow-Up Studies; Humans; Hypercalcemia; Imidazoles; Livedo Reticularis; Male; Middle Aged; Monitoring, Physiologic; Mouth Neoplasms; Risk Assessment; Treatment Outcome; Zoledronic Acid

2014
Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cells, Cultured; Cisplatin; Coloring Agents; Diphosphonates; Fibroblasts; Head and Neck Neoplasms; Humans; Imidazoles; Indicators and Reagents; Lasers, Semiconductor; Low-Level Light Therapy; Photochemotherapy; Photosensitizing Agents; Tetrazolium Salts; Zoledronic Acid

2014
Zoledronic acid and irradiation in oral squamous cell carcinoma.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2015, Volume: 44, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Humans; Imidazoles; Mouth Neoplasms; Radiotherapy Dosage; Time Factors; Zoledronic Acid

2015
Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion.
    Arquivos brasileiros de endocrinologia e metabologia, 2014, Volume: 58, Issue:6

    Topics: Bone Density Conservation Agents; Carcinoma, Squamous Cell; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Parathyroid Hormone; Pelvis; Penile Neoplasms; Rare Diseases; Tomography, X-Ray Computed; Zoledronic Acid

2014
Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
    European journal of pharmacology, 2015, Aug-15, Volume: 761

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Calcium; Calcium Chelating Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytochromes c; Diphosphonates; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Imidazoles; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid

2015
Pulmonary strongyloidiasis mimicking cancer symptoms: a case of hyperinfection in a patient with metastatic lung cancer.
    American journal of clinical oncology, 2008, Volume: 31, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Dexamethasone; Diagnosis, Differential; Diphosphonates; Gemcitabine; Humans; Imidazoles; Immunocompromised Host; Lung Diseases, Parasitic; Lung Neoplasms; Male; Strongyloidiasis; Superinfection; Zoledronic Acid

2008
Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.
    Cancer research, 2010, Nov-01, Volume: 70, Issue:21

    Topics: Acid Phosphatase; Animals; Bone Density Conservation Agents; Bone Resorption; Calcium; Carcinoma, Squamous Cell; Cats; Diphosphonates; Disease Models, Animal; Imidazoles; Isoenzymes; Luciferases; Male; Mice; Mice, Nude; Mouth Neoplasms; Osteoclasts; Osteolysis; Tartrate-Resistant Acid Phosphatase; Transplantation, Heterologous; X-Ray Microtomography; Zoledronic Acid

2010
Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Oncology reports, 2011, Volume: 25, Issue:4

    Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Caspases; Cell Cycle; Cell Proliferation; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Immunoenzyme Techniques; Mouth Neoplasms; Salivary Gland Neoplasms; Tumor Cells, Cultured; Zoledronic Acid

2011
Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2013, Volume: 26, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chromosomal Proteins, Non-Histone; Cisplatin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Esophageal Neoplasms; Esophagus; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Microfilament Proteins; Middle Aged; Neoplasm Staging; Prognosis; Proportional Hazards Models; Sex Factors; Survival Rate; Zoledronic Acid

2013
In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.
    Archives of oral biology, 2013, Volume: 58, Issue:6

    Topics: Adenocarcinoma; Annexin A5; Apoptosis; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cells, Cultured; Coloring Agents; Dental Cementum; Diphosphonates; Endothelial Cells; Endothelium, Vascular; Etidronic Acid; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gingiva; Humans; Imidazoles; Leukemia, Monocytic, Acute; Mesenchymal Stem Cells; Periodontal Ligament; Propidium; Tetrazolium Salts; Umbilical Veins; Zoledronic Acid

2013
Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer.
    Clinical lung cancer, 2005, Volume: 6, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Squamous Cell; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Lung Neoplasms; Middle Aged; Osteoarthropathy, Secondary Hypertrophic; Zoledronic Acid

2005
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
    The Lancet. Oncology, 2006, Volume: 7, Issue:11

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid

2006